Background illustration for clinical trials search

Paid Clinical Trials Denton

Discover 1,933 paid clinical trials in Denton, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

DALY II USA/ MB-CART2019.1 for DLBCL

for
Refractory Diffuse Large B Cell Lymphoma (DLBCL),
Location: Dallas TX, Houston TX, San Antonio TX, Westwood KS,
Sponsor: Miltenyi Biomedicine GmbH

Sex: All

Age: 18+

Code: NCT04792489

Phase2, Recruiting

Once Weekly Infant Corticosteroid Trial for DMD

for
Duchenne Muscular Dystrophy
Location: Dallas TX, Chicago IL, Cincinnati OH, Columbus OH
Sponsor: Anne M. Connolly

Sex: Male

Age: 0 - 2

Code: NCT05412394

Recruiting

Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN

for
IC-MPGN
Location: Dallas TX, Temple TX, Houston TX, St Louis MO,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 12 - 60

Code: NCT05755386

Phase3, Recruiting

Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)

for
Von Willebrand Diseases
Location: Dallas TX, Nashville TN, Aurora CO, Atlanta GA,
Sponsor: Vega Therapeutics, Inc

Sex: All

Age: 12 - 60

Code: NCT05776069

Phase1, Phase2, Recruiting

VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors

for
Solid Tumor, Rhabdomyosarcoma
Location: Dallas TX, Houston TX, Chicago IL, Cincinnati OH,
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 0 - 30

Code: NCT04796012

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer

for
Triple Negative Breast Cancer
Location: Dallas TX, Westwood KS, Germantown TN, St Louis MO,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT06926920

Phase1, Phase2, Recruiting

Generic Database of Very Low Birth Weight Infants

for
Infant, Newborn, Infant, Low Birth Weight,
Location: Dallas TX, Houston TX, Albuquerque NM, Birmingham AL,
Sponsor: NICHD Neonatal Research Network

Sex: All

Age: 0

Code: NCT00063063

Recruiting

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

for
Atrial Fibrillation, Stroke, Bleeding
Location: Plano TX, Houston TX, Little Rock AR, Kansas City MO,
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 18+

Code: NCT04045665

Phase3, Recruiting

Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) Multi-Site RCT

for
Head and Neck Cancer, Body Image Disturbance, Body Image,
Location: Dallas TX, St Louis MO, Detroit MI, Charleston SC,
Sponsor: Medical University of South Carolina

Sex: All

Age: 18+

Code: NCT05442957

Recruiting

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

for
Solid Tumor, Advanced Solid Tumor, Solid Tumor, Adult,
Location: Dallas TX, Austin TX, Little Rock AR, Nashville TN,
Sponsor: NiKang Therapeutics, Inc.

Sex: All

Age: 19+

Code: NCT06586957

Phase1, Recruiting

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

for
Refractory Ewing Sarcoma, Relapsed Ewing Sarcoma, Ewing Sarcoma
Location: Dallas TX, Houston TX, Memphis TN, Atlanta GA,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 2 - 30

Code: NCT05734066

Phase1, Phase2, Recruiting

Tocilizumab in Lung Transplantation

for
Lung Transplant
Location: Dallas TX, St Louis MO, Nashville TN, Atlanta GA,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 12 - 70+

Code: NCT06033196

Phase2, Recruiting

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: Dallas TX, Austin TX, Houston TX, Germantown TN,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136650

Phase3, Recruiting